Clinical Trial Update: Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a triplet regimen of liposomal irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin in Japanese patients with previously untreated me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan liposome injection (irinotecan liposome injection)
• Levoleucovorin (levoleucovorin)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Metastatic Adenocarcinoma of the Pancreas | Phase 2 | Status: ACTIVE_NOT_RECRUITING